Irritable Bowel Syndrome

On this page

IBS Basics - Gut Feeling Gone Wrong

  • Chronic functional GI disorder: Recurrent abdominal pain, altered bowel habits (diarrhea, constipation, or mixed). No organic pathology.
  • Pathophysiology: Gut-brain axis dysfunction, visceral hypersensitivity, altered motility, gut microbiota dysbiosis, low-grade inflammation.
  • Risk Factors: Genetics, stress, prior gastroenteritis (Post-Infectious IBS or PI-IBS), food intolerances.
  • Epidemiology: Affects ~10-15% of population; Female > Male.

⭐ Post-infectious IBS (PI-IBS) can develop in up to 20% of individuals after an episode of acute gastroenteritis.

  • Diagnosis of exclusion, based on symptom criteria (e.g., Rome IV).

Why Me? - IBS Inner Workings

  • Gut-Brain Axis Dysregulation: Core issue; bidirectional CNS-ENS miscommunication.
    • Psychological factors (stress, anxiety) significantly influence symptoms.
    • Serotonin (5-HT) signaling alterations impact motility and sensation.
  • Altered Gut Motility:
    • IBS-D: Accelerated colonic transit.
    • IBS-C: Delayed colonic transit.
  • Visceral Hypersensitivity: Heightened pain perception from normal gut stimuli.
    • Nerve endings in gut wall are oversensitive.
  • Gut Microbiota Imbalance (Dysbiosis):
    • Altered bacterial composition; Small Intestinal Bacterial Overgrowth (SIBO) link.
  • Low-Grade Inflammation & Immune Activation:
    • Subtle inflammation, ↑ mast cells, ↑ intestinal permeability ("leaky gut").

⭐ Post-infectious IBS (PI-IBS) develops in a subset of patients (approx. 10-20%) following an episode of acute bacterial gastroenteritis. Pathophysiology of IBS: Multifactorial Influences

Spotting IBS - Symptom Sleuthing

  • Core: Recurrent abdominal pain, altered bowel habits (diarrhea/constipation/mixed).
  • Rome IV Criteria (symptom onset ≥6 mo prior; active for last 3 mo):
    • Recurrent abd. pain (≥1 day/wk)
    • Associated with ≥2 of:
      • Pain linked to defecation
      • Stool frequency change
      • Stool form change (Bristol)
  • Subtypes (Bristol):
    • IBS-C: >25% hard, <25% loose stools
    • IBS-D: >25% loose, <25% hard stools
    • IBS-M: >25% hard & >25% loose
    • IBS-U: Unsubtyped
  • ⚠️ Alarm Features (Red Flags):
    • Onset >50 yrs, weight loss, nocturnal sx
    • Rectal bleeding, Fe def. anemia
    • Fam Hx: IBD, celiac, CRC

⭐ Rome IV: Key for diagnosis; positive criteria, not just exclusion.

Not Just IBS - Ruling Rivals Out

  • Key: Exclude organic pathology. Watch for alarm features:
    • Weight loss, rectal bleeding, anemia
    • Nocturnal symptoms, family Hx (CRC/IBD), age >50
  • IBD (Crohn's/UC): Endoscopy, biopsy.
  • Celiac Disease: Serology (anti-tTG), biopsy.
  • Infections (India): Amoebiasis, Giardiasis. Stool tests.
  • Lactose Intolerance: H2 breath test.
  • Colorectal Cancer: Colonoscopy if alarm signs.
  • Microscopic Colitis: Biopsy essential.

⭐ Nocturnal diarrhea is a key red flag pointing away from IBS towards organic causes like IBD or microscopic colitis.

Taming the Tumult - IBS Treatment Toolkit

  • Foundation: Reassurance, education, regular physical activity.
  • Dietary: Low FODMAP diet trial (key for bloating/pain).
  • Pharmacotherapy (Subtype-Guided):
    • IBS-C: Soluble fiber (psyllium), PEG; Lubiprostone, Linaclotide if needed.
    • IBS-D: Loperamide (acute); Rifaximin (550mg TID x 14d); Eluxadoline. Alosetron (severe, ♀, REMS).
    • Abdominal Pain: Antispasmodics (Dicyclomine), Peppermint oil. Low-dose TCAs (Amitriptyline 10-25mg).
  • Psychological: CBT, hypnotherapy, stress management.

⭐ Rifaximin, a gut-selective antibiotic, offers durable relief of bloating and abdominal pain in non-constipated IBS (IBS-D/M).

High‑Yield Points - ⚡ Biggest Takeaways

  • Rome IV criteria for diagnosis: recurrent abdominal pain related to defecation, or change in stool frequency/form.
  • Subtypes: IBS-C (constipation-predominant), IBS-D (diarrhea-predominant), IBS-M (mixed).
  • A functional bowel disorder; diagnosis of exclusion. Rule out organic disease.
  • Red flag symptoms (weight loss, bleeding, anemia) necessitate further investigation.
  • Management: low FODMAP diet, lifestyle changes, antispasmodics, loperamide, laxatives.
  • Pathophysiology involves visceral hypersensitivity, altered gut motility, and gut-brain axis dysfunction.
  • Often associated with psychological distress (anxiety, depression).

Practice Questions: Irritable Bowel Syndrome

Test your understanding with these related questions

Mechanism of action of teduglutide in short bowel syndrome:-

1 of 5

Flashcards: Irritable Bowel Syndrome

1/10

_____ (IBD) is Th1 mediated

TAP TO REVEAL ANSWER

_____ (IBD) is Th1 mediated

Crohn disease

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial